LOUISA TALI: Open Payments
NPI 1295476125 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 26 payments from 12 companies in 2025. Trend: 2023 $193 · 2024 $529 · 2025 $937
Food & beverage: $837Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $170 |
| Astellas Pharma US Inc | 4 | $154 |
| Corcept Therapeutics | 1 | $138 |
| Indivior Inc. | 4 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $111 |
| ABBVIE INC. | 3 | $79 |
| Lundbeck LLC | 2 | $49 |
| Boston Scientific Corporation | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
Products named: Korlym, SUBLOCADE, CAPLYTA, REXULTI, Veozah, BREZTRI, WaveWriter Alpha Prime 16, VRAYLAR.
Industry payments across UT — which companies pay providers there.
